Women's Studies 2244 Lecture Notes - Lecture 5: Corporatization, Michel Foucault, Oncology
Document Summary
Lecture 5 the corporatization of women"s health. Concern with how risks for future disease have come to be targets for medical. In neo-medicalization, the owners and makers of medical knowledge are not only media and consumers. Entangled with corporate interests (creation and marketing of pharmaceuticals). Neo-medicalization informed by neoliberal policies. physicians and medical researchers, but also corporate entities, government, the: multiple sites of knowledge construction, multiple sites of intervention and surveillance, multiple sites for contestation and resistance. Need to recall the precautionary principle (pertains to situations of scientific uncertainty) in order to provide women with authentic autonomy and real choices. Neo-medicalizing discourses on health risk have the potential to coopt feminist challenges to medicalization. Tamoxifen - lowered risk of brca in clinical trials but raised risk of endometrial cancer, cataracts and blood clots. Brief trajectory of breast cancer: breast cancer is understood and responded to. The role of corporate philanthropy in the construction and materialization of the.